Advertisement
Advertisement
VRDN
Viridian Therapeutics, Inc. Common Stock
20.47
USDSponsored
-0.19
-0.92%
Sep 25, 15:59 UTC -4
Closed
After-Market
20.47
0.00
0.00%
Viridian Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 2.32B |
| Beta | 0.97 |
| Earnings Per Share (EPS) | -3.37 |
| Price-to-Book (P/B) Ratio | 3.74 |
| Operating Margin | -505.86% |
| Total Debt/Equity (D/E) | 36.57% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -72.97% |
| Current Ratio | 16.95% |
| Free Cash Flow | -226.31M |